tickrz reports
Mallinckrodt Plc (MNK)
Healthcare | Drugs
23.36  1.08%
MNK vs DRUGS SECTOR & S&P 500
VALUATION
MNKSECTORS&P 500
P/E RATIO3.383820.18
EV/EBITDA RATIO6.28121.612.15
P/S RATIO0.726.22.14
P/B RATIO0.427.33.29
QUALITY
RETURN ON EQUITY12.41%15.79%13.65%
RETURN ON CAPITAL27.18%19.38%10.09%
NET MARGIN14.46%14.46%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY114%
INTEREST COVERAGE1.4x
CURRENT RATIO1.38
GROWTH
5 YR EPS GROWTH13.48%
5 YR SPS GROWTH10.83%
5 YR BPS GROWTH9.67%
About tickrz
Key Concepts
Great Investors
Mallinckrodt Plc ranks well on valuation
FACTOR RANKINGSFACTOR SCREENER 
TICKRZ MFM RANK A / 39PURE VALUE RANKA / 3
DIVIDEND RANKD / NO DIVIDENDMOAT RANKN/A
FINANCIAL STRENGTH RANKD / 320GROWTH RANKA / 60
MOMENTUM RANKD / 492
tickrz MFM rank A / 39
Mallinckrodt Plc receives an A ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here.
value
pure value ranking A / 3Warren Buffett ranking C / 360
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Mallinckrodt Plc's valuation score is comprised of a P/E ratio of 3.4x, a P/B ratio of 0.4x, a P/S ratio of 0.7x, and an EV/EBITDA ratio of 6.3x. Mallinckrodt Plc ranks 3 out of the S&P 500 constituents on valuation--a relatively strong score.Mallinckrodt Plc ranks 360 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Mallinckrodt Plc is probably not for you.

quality
moat N/Afinancial strength D / 320
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Unfortunately we don't have enough data to calculate Mallinckrodt Plc's Moat Rank.Mallinckrodt Plc has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 1.4x, a debt/equity ratio of 114% and a Moat Rank of 464 translate to a weak Financial Strength score.

momentum D / 492
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -61.83% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 492. Based on its 12 month stock performance, Mallinckrodt Plc will not appeal to momentum investors.

yield D / NO DIVIDEND
value + yield
Mallinckrodt Plc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth A / 60
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 13.5% 5 year annualized EPS growth, 10.8% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 9.7% speak to its impressive growth ranking.

Mallinckrodt Plc (MNK)
Healthcare | Drugs
23.36  1.08%


tickrz rank
A
VALUATION RATIOS
P/E Ratio3.38x
P/B Ratio0.42x
P/S Ratio0.72x
EV/EBITDA Ratio6.28x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY114%
INTEREST COVERAGE1.4x
CURRENT RATIO1.38
MOAT
ROE12.41%
ROIC27.18%
Net Margin14.46%
GROWTH
5 YR EPS GROWTH13.48%
5 YR SPS GROWTH10.83%
5 YR BPS GROWTH9.67%

TICKRZ RANK
Mallinckrodt Plc receives an A ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Mallinckrodt Plc's valuation score is comprised of a P/E ratio of 3.4x, a P/B ratio of 0.4x, a P/S ratio of 0.7x, and an EV/EBITDA ratio of 6.3x. Mallinckrodt Plc ranks 3 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Mallinckrodt Plc ranks 360 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Mallinckrodt Plc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Unfortunately we don't have enough data to calculate Mallinckrodt Plc's Moat Rank.

FINANCIAL STRENGTH
Mallinckrodt Plc has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 1.4x, a debt/equity ratio of 114% and a Moat Rank of 464 translate to a weak Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -61.83% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 492. Based on its 12 month stock performance, Mallinckrodt Plc will not appeal to momentum investors.

VALUE + YIELD
Mallinckrodt Plc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 13.5% 5 year annualized EPS growth, 10.8% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 9.7% speak to its impressive growth ranking.